Harmony Biosciences Holdings HRMY Earnings Call Transcripts

NASDAQ HRMY
$33.78 +0.67 (+2.02%)
At close: Nov 9, 2026 · 4:00 PM EST
22 earnings calls on file for Harmony Biosciences Holdings, from Q3 2020 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Harmony Biosciences Holdings Q3 2026 Earnings Call

Nov 4, 2026 9,554 words · 42 min read
  • Brennan DoyleHead of Investor Relations
  • Dr. Jeffrey DaynoPresident and Chief Executive Officer
  • Peter AnastasiouSenior Executive Vice President and Chief Operating Officer
  • Adam ZaeskeChief Commercial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Harmony Biosciences Holdings Earnings Call Transcripts

Calls22
LatestNov 4, 2026
SinceQ3 2020

Fiscal 2026

Fiscal 2025

Fiscal 2024

Fiscal 2023

Fiscal 2022

Fiscal 2021

Fiscal 2020

All 22 Harmony Biosciences Holdings transcripts Register to get access to Harmony Biosciences Holdings’s earnings call transcripts.